Yammine, who conducted a pilot study for use of GLP-1 agonist medication for smoking cessation, adds that, though the results were promising, they are preliminary and need to be validated in larger randomized clinical trials
Sattler FR, Castaneda-Sceppa C, Binder EF, Schroeder ET, Wang Y, Bhasin S, Kawakubo M, Stewart Y, Yarasheski KE, Ulloor J, Colletti P, Roubenoff R, Azen SP
AwazulWellness Packages Peptides BPC-157 (Body Protection Compound-157/Pentadecapeptide) Description: A healing peptide that promotes tissue repair and reduces inflammation
This research received no external funding.
Improper storage of GLP-1 medications can compromise their therapeutic effectiveness and potentially lead to inadequate glycaemic control or reduced weight management efficacy